Email a Friend
Printer Friendly
Slashdot It!
Submit to Reddit
Add to Facebook

Measuring and modeling blood flow in malaria

November 23, 2009

Fluid Dynamics Conference in Minneapolis next week highlights

WASHINGTON, D.C. -- When people have malaria, they are infected with Plasmodium parasites, which enter the body from the saliva of a mosquito, infect cells in the liver, and then spread to red blood cells. Inside the blood cells, the parasites replicate and also begin to expose adhesive proteins on the cell surface that change the physical nature of the cells in the bloodstream.

Experiments show that infected red blood cells are stiffer and stickier than normal ones -- in the later stages of the disease, up to 10 times stiffer. They also tend to adhere to the endothelial cells lining the vasculature, affecting the normal blood flow. This explains some of the common symptoms of malaria, such as anemia and joint pain.

Sticking to the walls of blood vessels is a survival mechanism for the parasite. In order to develop completely, it needs several days inside a red blood cell. Even though parasitized cells are nearly invisible for the immune system, they may be destroyed in the spleen while circulating freely in the bloodstream.

Doctoral student Dmitry Fedosov and Brown University professor George Karniadakis are studying how malaria infections affect the physical properties of red blood cells, and alter normal blood flow circulation. In particular, they examine an increase in blood flow resistance, and dynamics of infected cells in the bloodstream.

They also monitor the mechanical properties of infected red blood cells by measuring membrane temperature fluctuations, and through the response of a "microbead" that is attached to the cell and twisted. The measured properties are then used in modeling the flow of red blood cells in people infected with malaria. They also collaborate with the group of professor Subra Suresh at MIT, who obtain experimental measurements of the properties and the flow of healthy and infected cells.

"Our model predicts the dynamics of malaria-infected RBCs in the bloodstream, which anticipates the possible course of the disease," says Fedosov.

Recently they found that temperature fluctuations of infected red blood cell membranes measured in experiments are not directly correlated with the reported cell properties, hence suggesting significant influence of metabolic processes. They measured an increase in resistance to blood flow in the capillaries and small arterioles during the course of malaria and found that parasitized red blood cells have a "flipping" motion at the vessel wall that appears to be due to stiffness of the infected cells. The developed models will aid to make realistic predictions of the possible course of the disease, and enhance current malaria treatments.

The talk "Multiscale modeling of blood flow in cerebral malaria" by Dmitry Fedosov, Bruce Caswell, and George Karniadakis is at 6:12 p.m. on Sunday, November 22, 2009.

American Institute of Physics

Related Red Blood Cells Current Events and Red Blood Cells News Articles

Red Blood Cells Current Events and Red Blood Cells News RSS

UM researcher identifies novel treatment for pain in sickle cell disease
A University of Minnesota Medical School research team led by Kalpna Gupta, Ph.D., has discovered that cannibinoids offer a novel approach to ease the chronic and acute pain caused by sickle cell disease (SCD).

Toward making 'extended blood group typing' more widely available
Scientists are reporting an advance toward enabling more blood banks to adopt so-called "extended blood group typing," which increases transfusion safety by better matching donors and recipients.

Modulator of fetal hemoglobin switch may target sickle cell disease
A retired but well-preserved mechanism for regulating viruses that has worked its way into the human genome appears to modulate a switch between adult and fetal hemoglobin production, Medical College of Georgia researchers report.

A fateful pause
We take our blood for granted, but its creation requires a complicated series of steps, starting with the formation of blood stem cells during early embryonic development, followed by progressive differentiation into the progenitors of red cells, white cells and platelets, and ultimately the full set of blood cells.

Reprogrammed human blood cells show promise for disease research
Cells from frozen human blood samples can be reprogrammed to an embryonic stem-cell-like state, according to Whitehead Institute researchers. These cells can be multiplied and used to study the genetic and molecular mechanisms of blood disorders and other diseases.

Underwater sponges and worms may hold key to cure for malaria
Healing powers for one of the world's deadliest diseases may lie within sponges, sea worms and other underwater creatures.

Antioxidants may help prevent malaria complicaton that leads to learning impairment
Using an experimental mouse model for malaria, an international group of scientists has discovered that adding antioxidant therapy to traditional antimalarial treatment may prevent long-lasting cognitive impairment in cerebral malaria. Their findings were published online June 24, 2010, in the journal PLoS Pathogens.

Blood deficiencies are strong predictors of poor outcome
For healthcare professionals diagnosing primary Sjögren's Syndrome (pSS, an autoimmune disorder in which immune cells attack and destroy moisture-producing glands), the incidence of blood based deficiencies is the strongest predictor of a poor outcome in patients according to the results of a study presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy.

Stroke Prevention Study in Children with Sickle Cell Anemia, Iron Overload Stopped Early
The National Heart, Lung, and Blood Institute (NHLBI) has stopped a clinical trial evaluating a new approach to reduce the risk of recurrent stroke in children with sickle cell anemia and iron overload because of evidence that the new treatment was unlikely to prove better than the existing treatment.

Second-line CML drugs evoke faster, better front-line remissions
Two drugs approved for treatment of drug-resistant chronic myeloid leukemia provide patients with quicker, better responses as a first therapy than the existing front-line medication, according to two studies published online by the New England Journal of Medicine.

More Red Blood Cells Current Events and Red Blood Cells News Articles

	Red Blood Cell Aging (Advances in Experimental Medicine and Biology) by Antonio De Flora (Editor), Mauro Magnani (Editor)
	Red Blood Cell Substitutes by CRC This unique book integrates the expertise of over 50 authorities from the laboratories of industry, academia, the military, the government, and blood banks to present a cohesive and up-to-date summary of research strategies, clinical and commercial developments, and regulatory and economic issues pertaining to the formulation of safe and effective red blood cell substitutes. Red Blood Cell Substitutes examines regulatory and socioeconomic aspects of blood substitute products and global transfusion practices from the perspective of blood banks and the U.S. Food and Drug Administration elucidates the mechanisms of action and consequences of blood substitute administration elaborates on the interactions of red cell substitutes with organ systems as well as impact on human physiology...
	RED BLOOD CELL MINI PLUSH IN PETRI DISH by Giantmicrobes It's your life-but who's really in charge? These are some of the real life engineers that keep your body's well-oiled machine running smoothly. Always a bloody popular favorite. Includes Petri Dish and (3 mini microbes)
	Enfamil Nutramigen Lipil Hypoallergenic Infant Formula Powder, Iron Fortified, 16-Ounce Canisters (Pack of 6) by Enfamil Provides easy-to-digest, balanced nutrition for baby's first 12 months. Lipil is a blend of the nutrients DHA and ARA. DHA and ARA are also naturally found in breast milk and are important building blocks for a baby's brain and eyes. Experts agree on the many benefits of breast milk. If you choose to use infant formula, ask your doctor which Enfamil formula is best for your baby. Enfamil Nutramigen Lipil is a hypoallergenic formula for babies who cry excessively or develop other colic symptoms or rash due to milk protein allergy. Comes in a pack of six. Makes 113 fluid ounces. Must add water.
	Blood Cells Powerpoint Template - Blood Cells PPT Template by LoveHealth Get access to our Blood Cells PowerPoint Templates, Red Blood cells PowerPoint,Blood Cells PPT, Red Blood Cells PowerPoint Template at any time of day or night.
	Natural TF-Defense - Support iron absorption & maintain red blood cell integrity in pets by PetAlive What is TF-Defense? TF-Defense combines natural ingredients that are known for their supportive function on red blood cells and liver health. It will also support a healthy immune system functioning.
	CELL MODEL - RED BLOOD by TEDCO TOYS This hands-on interactive model provides magnified and cross-sectioned detailing of a red blood cell. Includes Ein-O's I Know Guide. OVERSIZED MULTI-COLORED
	Ein-O Science BioSigns Red Blood Cell by Tedco This hands-on interactive model provides magnified and cross-sectioned detailing of an Red Blood Cell. Includes Ein-O's I Know Guide. The I Know Guide includes an introduction and info-briefs on the cell membrane, cytoplasm, and haemoglobin. Also, the instruction booklet has coated pages, so a bit more heavy duty for kids' use. Everything is included in a reusable plastic box. Ages 7 and up.
	You were a single red blood cell but I lost you in this knot of capillaries Wise Children (Primary Contributor)
	Cancer Patients and Anemia (Home Use) Part of the award winning public television series Healthy Body/Healthy Mind. Anemia (an abnormally low number of red blood cells) is a common condition in cancer patients that may occur either as a direct result of the cancer or as a side effect of the cancer treatment. Chemotherapy, radiation therapy, and blood loss during surgery are all common causes of anemia in cancer patients. But, as you'll see in this program, anemia can be successfully treated, and patients can go on to beat their cancers and live healthy lives. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply.